BALPHARMA vs RELIANCE
Head-to-head DCF comparison · BAL PHARMA LTD. vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
BALPHARMA
BAL PHARMA LTD.
General/Diversified
₹85
Data LimitedRELIANCE
Reliance Industries
Oil & Gas
₹1,263
Near Fair Value| Metric | BALPHARMA | RELIANCE |
|---|---|---|
| Verdict | Data Limited | Near Fair Value |
| YieldIQ Score | 43/100 | 67/100 |
| Fair Value | ₹43 | ₹1,500 |
| Current Price | ₹85 | ₹1,263 |
| Discount to FV | -49.8% | +18.7% |
| Moat | Narrow | Moderate |
| Piotroski F-Score | 6/9 | 4/9 |
| ROE | — | 8.9% |
| Debt / Equity | 1.94 | 0.37 |
| EV / EBITDA | 11.9× | 9.8× |
| Market Cap | ₹135.53 Cr | ₹17.09 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.